Lactobacillus plantarum 299v and Reduced Flatulence

Across 3 studies, 2 reported beneficial effects (1 small, 1 large) and 1 found no significant benefit (neutral, small effect) for reduced flatulence. The evidence is preliminary and mixed, with the only RCT in IBS patients showing no significant effect, while a large observational study in IBS patients and a small RCT in cancer patients on enteral nutrition both reported significant reductions. The most studied population is adults with IBS, and doses ranged from 1×10^10 to 2×10^10 CFU per day; study durations were not consistently reported.

• Effective dose range: 1×10^10 to 2×10^10 CFU per day
• Studied populations: irritable bowel syndrome patients, cancer patients receiving home enteral nutrition

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Findings are inconsistent: the highest-quality study (RCT, n=190) found no significant effect on flatulence, while two lower-quality studies (observational and small RCT) reported significant benefits. The beneficial effects may be limited to specific subgroups or longer treatment durations, but data are insufficient to confirm.